Alkeus Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
53
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$150M
- Investors
-
8
Alkeus Pharmaceuticals General Information
Description
Operator of a clinical-stage biopharmaceutical company intended to develop treatments against serious and untreatable diseases of the eye. The company's lead drug candidate is an orally delivered compound that could potentially treat Stargardt disease and age-related macular degeneration, enabling medical professionals to treat symptoms of irreversible vision loss early in life in patients.
Contact Information
Website
www.alkeuspharma.comCorporate Office
- 2464 Massachusetts Avenue
- Suite 314
- Cambridge, MA 02140
- United States
Corporate Office
- 2464 Massachusetts Avenue
- Suite 314
- Cambridge, MA 02140
- United States
Alkeus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 28-Apr-2023 | $150M | Completed | Clinical Trials - Phase 3 | ||
| 4. Grant | 30-Apr-2019 | Completed | Clinical Trials - Phase 3 | |||
| 3. Grant | 01-Jul-2018 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 01-Jan-2012 | $165K | $100K | Completed | Startup | |
| 1. Accelerator/Incubator | 21-Oct-2010 | $100K | $100K | Completed | Startup |
Alkeus Pharmaceuticals Comparisons
Industry
Financing
Details
Alkeus Pharmaceuticals Competitors (2)
One of Alkeus Pharmaceuticals’s 2 competitors is Belite Bio, a Formerly Accelerator/Incubator backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Belite Bio | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
| Endogena Therapeutics | Venture Capital-Backed | Zurich, Switzerland |
Alkeus Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alkeus Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alkeus Pharmaceuticals Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bain Capital Life Sciences | Corporate Venture Capital | Minority | ||
| Sofinnova Investments | Venture Capital | Minority | ||
| TCG Crossover Management | Venture Capital | Minority | ||
| Wellington Management | Asset Manager | Minority | ||
| National Eye Institute | Government |
Alkeus Pharmaceuticals FAQs
-
When was Alkeus Pharmaceuticals founded?
Alkeus Pharmaceuticals was founded in 2010.
-
Where is Alkeus Pharmaceuticals headquartered?
Alkeus Pharmaceuticals is headquartered in Cambridge, MA.
-
What is the size of Alkeus Pharmaceuticals?
Alkeus Pharmaceuticals has 53 total employees.
-
What industry is Alkeus Pharmaceuticals in?
Alkeus Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Alkeus Pharmaceuticals a private or public company?
Alkeus Pharmaceuticals is a Private company.
-
What is Alkeus Pharmaceuticals’s current revenue?
The current revenue for Alkeus Pharmaceuticals is .
-
How much funding has Alkeus Pharmaceuticals raised over time?
Alkeus Pharmaceuticals has raised $150M.
-
Who are Alkeus Pharmaceuticals’s investors?
Bain Capital Life Sciences, Sofinnova Investments, TCG Crossover Management, Wellington Management, and National Eye Institute are 5 of 8 investors who have invested in Alkeus Pharmaceuticals.
-
Who are Alkeus Pharmaceuticals’s competitors?
Belite Bio and Endogena Therapeutics are competitors of Alkeus Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
